Affiliation:
1. Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
2. Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20142 Milan, Italy
Abstract
Gastric cancer is one of the leading causes of cancer deaths worldwide, with chronic gastritis representing the main predisposing factor initiating the cascade of events leading to metaplasia and eventually progressing to cancer. A widely accepted classification distinguishes between autoimmune and environmental atrophic gastritis, mediated, respectively, by T cells promoting the destruction of the oxyntic mucosa, and chronic H. pylori infection, which has also been identified as the major risk factor for gastric cancer. The original dogma posits Th1 immunity as a main causal factor for developing gastritis and metaplasia. Recently, however, it has become evident that Th2 immune responses play a major role in the events causing chronic inflammation leading to tumorigenesis, and in this context, many different cell types and cytokines are involved. In particular, the activity of cytokines, such as IL-33 and IL-13, and cell types, such as mast cells, M2 macrophages and eosinophils, are intertwined in the process, promoting chronic gastritis-dependent and more diffuse metaplasia. Herein, we provide an overview of the critical events driving the pathology of this disease, focusing on the most recent findings regarding the importance of Th2 immunity in gastritis and gastric metaplasia.
Funder
Crohn’s & Colitis Foundation Career Development
Senior Research
National Institutes of Health (NIDDK) Silvio O. Conte Cleveland Digestive Diseases Research Core Center
Reference137 articles.
1. (2021, October 12). Estimated Age-Standardized Mortality Rates (World) in 2020, Worldwide, Both Sexes, All Ages. Available online: https://gco.iarc.fr/today/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Afalse%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D.
2. Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., and Sitarz, R. (2020). Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int. J. Mol. Sci., 21.
3. Liu, X., and Chu, K.M. (2014). E-cadherin and gastric cancer: Cause, consequence, and applications. Biomed. Res. Int., 2014.
4. The gastric precancerous cascade;Correa;J. Dig. Dis.,2012
5. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients;Uemura;Aliment. Pharmacol. Ther.,1997